Tempus AI launches effort to build 100,000 whole-genome dataset linked to clinical outcomes

Reuters2026/09/11 12:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tempus AI launched an initiative to build a research platform of 100,000 disease-specific whole-genome sequences linked to longitudinal clinical outcomes.
The project targets AI-driven research, positioning the dataset as model-ready within its de-identified multimodal data environment.
Tempus set a long-term goal to expand the platform to 1 million genomes.
Initial access is available via an Early Adopter Program, with general availability targeted for mid-2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609110830BIZWIRE_USPR_____20260911_BW945729) on September 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tempus AI launches effort to build 100,000 whole-genome dataset linked to clinical outcomes

You may also like

Crypto prices